PROVIDER PROFILE · NPI 1457425795
Myra BelcherRN,CSN,BSN,NP
PRESCRIBING · PART D · 2024
Total Rx claims
1,853
Beneficiaries
—
Total drug cost
$2.7M
Distinct drugs
47
Brand share
50.8%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala324 claims
Dolutegravir Sodium118 claims
Emtricitabine/Tenofov Alafenam103 claims
Rosuvastatin Calcium94 claims
Dolutegravir Sodium/Lamivudine75 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK
Where Myra Belcher's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Tucker, GA | 54 | 192 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE